C5AR1 and neoplasm: C5aR1 showed a negative correlation with the immunological status of TME and a positive correlation with most immune checkpoints in GC, including PD-L1, CTLA-4, LAG-3, and PD-1, which suppress the effector function of T cells and impede anti-tumor immunity.